The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions. Crowe A, Linder A, Hameed O, Salih C, Roberson J, Gidley J, Eltoum IA (2011) Cancer Cytopathol 119: 315-21 Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules. Weiss VL, Andreotti RF, Ely KA (2018) Cancer Cytopathol 126: 518-524 Incidence and malignancy rates of indeterminate pediatric thyroid nodules. Wang H, Mehrad M, Ely KA, Liang J, Solórzano CC, Neblett WW, Coogan AC, Weiss VL (2019) Cancer Cytopathol 127: 231-239 Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules. Méndez W, Rodgers SE, Lew JI, Montano R, Solórzano CC (2008) Ann Surg Oncol 15: 2487-92 Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Jabiev AA, Ikeda MH, Reis IM, Solorzano CC, Lew JI (2009) Ann Surg Oncol 16: 3140-5 Use of ultrasound in the management of thyroid cancer. Lew JI, Solorzano CC (2010) Oncologist 15: 253-8 Quantitative analysis of tumor vascularity in benign and malignant solid thyroid nodules. Lyshchik A, Moses R, Barnes SL, Higashi T, Asato R, Miga MI, Gore JC, Fleischer AC (2007) J Ultrasound Med 26: 837-46 Surgeon-performed ultrasound in the management of thyroid malignancy. Solorzano CC, Carneiro DM, Ramirez M, Lee TM, Irvin GL (2004) Am Surg 70: 576-80; discussion 580-2
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.